Introduction {#s01}
============

Oxidative protein folding in the ER relies on protein disulfide isomerase (PDI) machinery that accepts electrons from client cysteine thiols generating native disulfides ([@bib9]). A major advance in our understanding of this machinery came with the discovery of an ER-localized PDI oxidase, endoplasmic reticulum oxidase 1 (ERO1; [@bib5]; [@bib15]), which accepts electrons from reduced PDI and hands them over to molecular oxygen, catalyzing oxygen-mediated disulfide bond formation ([@bib21]; [@bib1]). ERO1 is conserved in eukaryotes. The marked impairment in disulfide bond formation in yeast lacking ERO1 suggested an essential role in accelerating dithiol oxidation in the ER ([@bib5]; [@bib15]). Surprisingly, targeted mutagenesis of the genes encoding animal ERO1 orthologues, *ERO1L/*ERO1α and *ERO1LB/*ERO1β, revealed a remarkably mild phenotype ([@bib20]; [@bib25]).

In ERO1-deficient cells and tissues, life-sustaining rates of disulfide bond formation depend on the ER-localized enzyme peroxiredoxin 4 (PRDX4; [@bib26], [@bib27]). PRDX4 accepts electrons from reduced PDI and transfers them to hydrogen peroxide (H~2~O~2~; [@bib17]; [@bib26]). ERO1-mediated electron transfer from reduced PDI to oxygen reduces the latter to H~2~O~2~ ([@bib6]). Thus, the sequential action of ERO1 and PRDX4 can produce two disulfides from every molecule of oxygen converted to water.

Though it is dispensableunder normal circumstances ([@bib10]), the PRDX4-mediated reaction becomes limiting in cells lacking ERO1 ([@bib26]), but the identity of the source of H~2~O~2~ that fuels PRDX4 in cells lacking ERO1 is unknown. Resolving this mystery has been hampered by difficulties in measuring changes in H~2~O~2~ concentration in the ER of living cells. To circumvent this issue, we exploited the kinetic properties of intravital fluorescent thiol redox probes that diverge in their reactivity with the oxidized/reduced PDI couple and H~2~O~2~. Our studies point to an ER-localized, ERO1-independent source of H~2~O~2~ that fuels PRDX4-mediated disulfide bond formation in cells lacking ERO1.

Results and discussion {#s02}
======================

PRDX4-mediated ER thiol oxidation is fueled by H~2~O~2~ independently of ERO1 {#s03}
-----------------------------------------------------------------------------

Combined deficiency of ERO1 and PRDX4 is detrimental to mammalian development and enhances lethality of mutant mice. Nonetheless, enfeebled, viable compound mutant cell lines can be cultured in vitro ([@bib27]). Remarkably, such triple-mutant cells (referred to as triple knockout \[TKO\]; *Ero1I^Gt(xst171)Byg/Gt(XST171)Byg^; Ero1Ib^Gt(P077G11)Wrst/Gt(P077G11)Wrs^; Prdx4^tm1.1JuFu/tm1.1JuFu^*) defend a steady-state PDI thiol redox couple that is indistinguishable from wild-type cells. However, the deficit in oxidative power of the TKO cells is revealed in a kinetic assay that tracks recovery of disulfide bonds after a reductive pulse of DTT ([@bib2]).

These measurements were previously performed by tracking changes in the fluorescence lifetime of an ER-localized intravital redox probe based on GFP containing E147 insertion (ERroGFPiE) that equilibrates rapidly with PDI and is specially tuned to PDI's oxidative state found in the ER ([@bib11]; [@bib2]). However, this theoretical advantage of ERroGFPiE is obviated by the normal steady state of the PDI redox couple in TKO cells. Furthermore, the fluorescent lifetime imaging measurements necessary to track the redox state of the ER-tuned roGFPiE are difficult to acquire. Therefore, we sought an alternative method to detect the kinetic defect in ER thiol reoxidation observed in TKO cells after a DTT pulse.

ER-localized roGFP2 (ERroGFP2) is recognized as a substrate by PDI, and kinetic parameters deduced from the recovery of its oxidized state after a DTT pulse and washout thus reflect the activity of the enzymatic machinery for PDI reoxidation in vivo ([@bib22]). Its enhanced brightness enables measuring its redox state ratiometrically, by comparing the emission intensity of the probe at 530 nm when excited at 405 and 488 nm ([@bib8]), and it does not require the more exacting measurements of fluorescent lifetime.

The genetic defect in mouse fibroblasts lacking key ER redox enzymes was confirmed: ERO1α, normally present in fibroblasts, was undetectable in homozygous double knockout (DKO) mutant *Ero1I^Gt(xst171)Byg/Gt(XST171)Byg^*, *Ero1Ib^Gt(P077G11)Wrst/Gt(P077G11)Wrst^* mouse embryonic fibroblasts (MEFs) and in TKO mutants that are also homozygous for a null allele of *Prdx4^tm1.1JuFu/tm1.1JuFu^*. PRDX4 was readily detected in fibroblasts and was eliminated by mutation of its encoding gene, whereas the pancreatic-specific isoform of ERO1, ERO1β, was undetectable in fibroblasts of all genotypes tested ([Fig. 1 A](#fig1){ref-type="fig"}).

![**PRDX4 supports a near normal rate of ER thiol oxidation in the absence of ERO1.** (A) Immunoblot of endogenous Ero1α, Ero1β, and Prdx4 in lysates of MEFs with the indicated genotypes: wild-type (WT), *Ero1α; Ero1β* double mutant (DKO), *Ero1α; Ero1β; Prdx4* triple mutant (TKO), and *Prdx4* single mutant (PKO). An anti-actin blot serves as the loading control. (B) Fluorescent photomicrographs of MEF cells transiently expressing ERroGFP2, immunostained for calreticulin as an ER marker. The merge panels show an overlap of the GFP signal with calreticulin and the karyophilic dye Hoechst 33258 (to reveal the nuclei). (C--G) Traces of time-dependent changes in the fluorescence excitation ratio, reflecting the alterations in the oxidation state of roGFP2 expressed in the ER of cells with the indicated genotypes: WT, DKO, TKO, and TKO expressing an active, PRDX4^WT^, or inactive, PRDX4^C127S^, enzyme. Cells were exposed to a brief (1 min) reductive pulse of DTT (2 mM), followed by a washout. Each line traces the fluorescence profile of an individual cell. (H) Bar diagram of the *t*~1/2~ to recovery of the oxidized form of ERroGFP2 after the reductive DTT pulse, calculated from fitting the data in C--G. Shown are means ± SEM (*n* \> 20). \*, P \< 0.05; \*\*, P \< 0.01.](JCB_201506123_Fig1){#fig1}

As expected, ERroGFP2 was localized to the ER of transfected mouse fibroblasts ([Fig.1 B](#fig1){ref-type="fig"}) and was rapidly reoxidized after a DTT reductive pulse and washout of the reductant ([Fig.1 C](#fig1){ref-type="fig"}). The conversion of the reduced probe to its oxidized, pretreatment steady state (reoxidation phase) occurs with a *t*~1/2~ of 1.7 ± 0.3 min in wild-type MEFs ([Fig. 1, C and H](#fig1){ref-type="fig"}), whereas the reoxidation was approximately fivefold slower in TKO cells (*t*~1/2~ of 9.28 ± 0.8 min; [Fig.1, D and H](#fig1){ref-type="fig"}). These values, obtained for ERroGFP2, are in agreement with earlier measurements performed with the ER-tuned probes ERroGFPiL in HT1080 cells and ERroGFPiE in wild-type and TKO MEF cells ([@bib23]; [@bib2]).

In cells with wild-type ERO1 activity, PRDX4 has no measureable effect on the rate of ER thiol reoxidation after a DTT pulse ([Fig. S1](http://www.jcb.org/cgi/content/full/jcb.201506123/DC1){#supp1}). Although PRDX4 inactivation by excess ERO1-driven H~2~O~2~ production in DTT pulsed cells may underestimate PRDX4's normal role in thiol oxidation ([@bib16]), our observations are consistent with the inconspicuous phenotype of *Prdx4^tm1.1JuFu/tm1.1JuFu^* (peroxiredoxin 4 knockout \[PKO\]) mice ([@bib10]). Conversely, lack of ERO1 measurably delayed oxidation kinetics because a consistently longer *t*~1/2~ was measured in ERO1-deficient DKO cells (which contain PRDX4; [Fig. 1 A](#fig1){ref-type="fig"}, lane 2) than in their isogenic control ([Fig. 1, E and H](#fig1){ref-type="fig"}). Nevertheless, the importance of PRDX4 to the kinetics of disulfide bond formation in cells lacking ERO1 was highlighted by the restoration of the *t*~1/2~ of recovery of oxidized ERroGFP2 in TKO cells transduced with wild-type PRDX4 and by the inactivity of the enzymatically inactive PRDX4^C127S^ mutant lacking the peroxidiac cysteine ([Fig. 1, F--H](#fig1){ref-type="fig"}). These observations confirm that PRDX4 assumes an important role in the kinetics of disulfide bond formation when ERO1 activity is limiting, and they correlate with the previous phenotypic analysis of compound mutant cells ([@bib26]).

Compartment-specific responsiveness of the H~2~O~2~-sensitive probe HyPer reveals a barrier to oxidant diffusion across the ER membrane {#s04}
---------------------------------------------------------------------------------------------------------------------------------------

The above observations raised the question of the source of the oxidative process that fuels PRDX4 recycling from its reduced to its oxidized state in ERO1-deficient cells lacking the major known source of H~2~O~2~ production in the ER lumen. To address this question, we sought tools to estimate changes in lumenal H~2~O~2~ concentration.

HyPer is a genetically encoded in vivo sensor for fluctuations in H~2~O~2~ concentration. It is based on direct H~2~O~2~-mediated formation of a disulfide bond between peroxidiac cysteine^199^ that reacts with H~2~O~2~ to form a sulfenic acid (and water) and the resolving cysteine^208^ of the *Escherichia coli* peroxide sensor OxyR ([@bib24]). The intramolecular C^199^-C^208^ disulfide is coupled to changes in the probes' fluorescent properties by incorporating the OxyR sensor into a circularly permuted YFP ([@bib4]; [@bib13]). In normally reduced cellular compartments, such as the cytosol and mitochondrial matrix, reduced thioredoxin maintains the OxyR cysteines in their reduced state, ready to respond to H~2~O~2~ ([@bib4]). In the ER, however, HyPer is severely compromised in its ability to sense H~2~O~2~, likely by a competing H~2~O~2~-independent, disulfide exchange--mediated formation of a C^199^-C^208^ disulfide ([@bib12]; [@bib14]).

Inactivation of ER-localized HyPer fits well with our observation that HyPer readily served as a substrate for oxidized PDI ([Fig. 2 A](#fig2){ref-type="fig"} and [Fig. S2](http://www.jcb.org/cgi/content/full/jcb.201506123/DC1){#supp2}). However, these same in vitro experiments revealed an important kinetic advantage to H~2~O~2~ over oxidized PDI in converting HyPer from its reduced to its oxidized form ([Fig. 2 A](#fig2){ref-type="fig"}; and Fig. S2, A and B). To determine whether this kinetic advantage could be exploited to sense H~2~O~2~ in the ER, we compared the effect of exogenous H~2~O~2~ on the rate of reoxidation of ERHyPer with that of ERroGFP2, which is indifferent to H~2~O~2~ ([@bib7]), in a DTT washout experiment in TKO cells. H~2~O~2~ enhanced the typically sluggish reoxidation of ERHyPer but had no effect on ERroGFP2 (Fig. S2, C and D).

![**ERHyPer responds to exogenous H~2~O~2~ in a chemically imposed reducing environment.** (A) Plot of the rate of in vitro oxidation of HyPer (1 µM) as a function of H~2~O~2~ or oxidized PDI (PDI~ox~) concentration, calculated from the linear phase of the initial oxidation reaction traced ratiometrically ([Fig. S2](http://www.jcb.org/cgi/content/full/jcb.201506123/DC1){#supp3}). (B) Schema representing response modes of ERroGFP2 and ERHyper. Both probes undergo oxidation by PDI. Unlike roGFP2, reduced HyPer also undergoes rapid oxidation by H~2~O~2~. Thus, HyPer's responsiveness to H~2~O~2~ can be unmasked in settings with a low concentration of oxidized PDI. (C) Traces of time-dependent changes to the redox-sensitive excitation ratio of HyPer exposed to various concentrations of H~2~O~2~ in vitro, in the continued presence of DTT. (D) Fluorescent photomicrographs of MEFs transiently transfected with ERHyPer encoding vector, immunostained for calreticulin, as an ER marker. (E) Trace of time-dependent changes to the oxidation state of ERHyPer (top plot) or ERroGFP2 (bottom plot) expressed in MEF cells challenged repeatedly with H~2~O~2~ (arrows) in the continuous presence of DTT. The general oxidant, diamide, was added in excess, to reveal the responsiveness of both probes at the end of the experiment. (F) Trace of time-dependent changes to the redox state of ERHyPer expressed in MEF cells, first briefly exposed to DTT, followed by wash out, and then exposed to DTT, followed by introduction of H~2~O~2~ to the reducing medium.](JCB_201506123_Fig2){#fig2}

The reactivity of HyPer with PDI observed in vitro ([Fig. 2 A](#fig2){ref-type="fig"}) explains the inactivity of the probe in the ER under baseline conditions ([Fig. 2 B](#fig2){ref-type="fig"}). Furthermore, in wild-type cells, with a normal complement of ERO1, PDI-driven reoxidation of HyPer dominates, precluding detection of H~2~O~2~. However, if H~2~O~2~ oxidation of HyPer were to exceed the rate of its reduction by a counteracting reductant (e.g., DTT), changes in H~2~O~2~ could be detected in the face of the continued presence of a reductant, neutralizing the contribution of PDI. Therefore, we tested the ability of HyPer to respond to H~2~O~2~ in vitro in the presence of DTT.

[Fig. 2 C](#fig2){ref-type="fig"} indicates that in vitro HyPer retains sensitivity to low concentrations of H~2~O~2~ (0--7 µM) in the presence of higher concentration of DTT (2 mM). These features are also observed in vivo, as in wild-type cells exposed continuously to 2 mM DTT (a concentration sufficient to fully reduce PDI thiols), addition of H~2~O~2~ led to a rapid oxidation of ERHyPer but not ERroGFP2 ([Fig. 2, D and E](#fig2){ref-type="fig"}). Reoxidation of HyPer by H~2~O~2~ in the presence of DTT was faster than that afforded by the core machinery after DTT washout ([Fig. 2 F](#fig2){ref-type="fig"}, compare the first and second oxidation phases). Moreover, the presence of DTT had no observable effect on the response of cytosolically located HyPer (cytoHyPer) exposed to a gradient of H~2~O~2~ ([Fig. 3 A](#fig3){ref-type="fig"}). These observations are consistent with rapid formation of the OxyR disulfide by reaction with H~2~O~2~ and its slow reduction by DTT, paralleling the hierarchy observed with PDI ([Fig. 2, A and B](#fig2){ref-type="fig"}).

![**Sluggish transit of H~2~O~2~ into the ER lumen.** (A) Plot showing the dependence of the redox state of cytoHyPer-expressed in RINm5F cells (measured by excitation ratio) on concentration of H~2~O~2~, introduced to the culture medium in the continued presence or absence of DTT (2 mM). (B) Plot of the relationship between HyPer oxidation state (linearly normalized, by setting the maximal observed value to 1 and the minimal observed value to 0) in the different compartments and concentration of H~2~O~2~ in the media in RINm5F cells exposed continuously to DTT (as in A). (C) Bar diagram of the mean H~2~O~2~ concentration in the culture media required to effect 50% of maximal oxidation of cytosolic, mitochondrial, or ER-localized HyPer (the midpoint in the traces shown in B; mean ± SEM, *n* = 4). \*\*, P \< 0.01. (D) Titration of H~2~O~2~ as described in C, performed in the presence of DTT in RINm5F or MEF cells. Note the enhanced sensitivity of RINm5F cells compared with the MEFs.](JCB_201506123_Fig3){#fig3}

Having developed a measurement method responsive to exogenously imposed changes in H~2~O~2~ concentration in the ER, we next set out to compare the responsiveness of cytoHyPerand mitochondrial HyPer and ERHyPer to mounting concentrations of exogenous H~2~O~2~. Remarkably, reoxidation of ERHyPer by exogenous H~2~O~2~ was considerably less efficient than that of the cytosolic or mitochondrially localized probe (midpoint of 33.2, 13.2, and 12.8 µM of extracellular H~2~O~2~, respectively; [Fig. 3, B and C](#fig3){ref-type="fig"}). To minimize the potential impact of ROS quenching enzymes in the various cellular compartments, we chose to perform these experiments in catalase/peroxidase-deficient RINm5F pancreatic cells ([@bib18]). In our system, this deficiency is manifested by higher sensitivity of cytoHyPer to a gradient of H~2~O~2~ ([Fig. 3 D](#fig3){ref-type="fig"}).

The H~2~O~2~-mediated ER thiol oxidation pathway relies on an internal ER source of the oxidant {#s05}
-----------------------------------------------------------------------------------------------

The aforementioned observations suggest the existence of a functional barrier to the rapid diffusion of H~2~O~2~ to the ER and therefore an ER source of H~2~O~2~ to fuel PRDX4-mediated disulfide bond formation, even in cells lacking ERO1. To further explore this possibility, we sought to selectively eliminate H~2~O~2~ from the different compartments by localized expression of catalase and then monitor the effects on ER thiol oxidation rate in DKO cells, a system in which this parameter is dependent on H~2~O~2~-fueled PRDX4 activity.

Targeting catalase to the cytosol, mitochondria, or ER markedly elevated the total catalase activity in lysates of transfected cells, indicating that the enzyme was active in all three compartments ([Fig. 4 A](#fig4){ref-type="fig"}). Activity of catalase was further confirmed by the observation that its presence in any of the three compartments attenuated the response of a colocalized HyPer to exogenous H~2~O~2~ ([Fig. 4, B--D](#fig4){ref-type="fig"}). The (obligatory) presence of DTT in the assay of ER catalase ([Fig. 4 D](#fig4){ref-type="fig"}) and differences in compartment size, obscure the correlation between catalase expression level and the magnitude of the attenuating effect on colocalized HyPer. Nonetheless, our observations point to the activity of catalase in all three compartments.

![**Purging the ER of its H~2~O~2~ content selectively retards PRDX4-mediated ER oxidation.** (A) Bar diagram showing specific activities of catalase in extracts of untransfected MEF^DKO^ cells and cells expressing catalase variants targeted to the indicated compartments. (B--D) Plot of the relationship between H~2~O~2~ concentration in the media and the excitation ratio of cytoHyper, mitochondrially located HyPer (mitoHyPer), or ERHyPer, expressed alone or alongside catalase in MEF^DKO^ cells (with insets of fixed anti-catalase immunostained cells showing the localization of the protein). The titration measuring the ER-localized probe was performed in presence of 2 mM DTT. The plots are presented along their corresponding ratiometric photomicrographs (B--D, bottom panels). The catalase-expressing cells are marked by the coexpression of mCherry (encoded on the same plasmid, denoted by white arrows). Note, the ratio indicates a more reduced state (color coded in blue-green) at the intermediate H~2~O~2~ concentration in catalase-positive cells compared with the mostly oxidized state (color coded yellow-red) in catalase-negative cells, as the latter are desensitized to H~2~O~2~ by catalase overexpression. (E) Traces of oxidation recovery of ERroGFP2 after a DTT pulse (2 mM, 1 min) in MEF^DKO^ cells with catalase expressed in the indicated compartments. (F) Bar diagram of the *t*~1/2~ to recovery of the oxidized form of ERroGFP2 after the reductive DTT pulse, calculated from fitting the data in E. Shown are mean *t*~1/2~ values ± SEM (*n* \> 10; \*\*, P \< 0.01). (G) Traces of oxidation recovery of ERroGFP2 after a DTT (2 mM, 1 min) pulse in parental TKO cells \[Cat(−)\] and TKO cells expressing catalase in their ER \[ER Cat\], identified by the presence of the coexpressed mCherry marker, as in E--G\]. Inset shows a bar diagram of the corresponding ERroGFP2 reoxidation *t*~1/2~ values. Shown are means ± SEM (*n* \> 10).](JCB_201506123_Fig4){#fig4}

Despite their ability to degrade cytosolic and mitochondrially localized H~2~O~2~, neither cytosolic nor mitochondrially localized catalase affected the rate of reformation of disulfide bonds in the ER: the *t*~1/2~ to recovery of ERroGFP2 in DKO cells after a DTT pulse was similar in untransfected cells and cells transfected with cytosolic or mitochondrially localized catalase ([Fig. 4, E and F](#fig4){ref-type="fig"}). In contrast, ER-localized catalase markedly attenuated the reoxidation of the H~2~O~2~ inert ERroGFP2 in DKO cells, increasing its *t*~1/2~ to recovery from 2.8 ± 0.6 to 10.9 ± 1.24 min (compare the red and purple traces in [Fig. 4 E](#fig4){ref-type="fig"}). Thus, ER catalase eliminates the effect of PRDX4, converting DKO cells to functionally TKO cells.

In contrast, ER catalase had no effect on the rate of ERroGFP2 reoxidation in TKO cells, lacking the H~2~O~2~-using enzyme PRDX4 ([Fig. 4 G](#fig4){ref-type="fig"}). Together, these observations support the conclusion that the attenuated reoxidation of ERroGFP2 in the DKO cells reflects the depletion of H~2~O~2~, an essential substrate of PRDX4. Moreover, the lack of an effect of ER catalase on the rate of disulfide bond formation in cells lacking PRDX4 (TKO cells; [Fig. 4 G](#fig4){ref-type="fig"}) suggests a nonredundant role for PRDX4 in using ER H~2~O~2~ as an oxidant to drive ER thiol oxidation in the absence of ERO1 and indicates the existence of an additional, slow, residual H~2~O~2~-independent mechanism for disulfide formation in TKO cells.

Our findings are consistent with the evolution of an ER-localized ERO1-independent mechanism for disulfide bond formation consisting of PRDX4 and an alternative lumenal source of H~2~O~2~. For now, the physiological significance of this backup mechanism remains obscure, because the bland phenotype of the PRDX4-deficent mouse provides no clues. Nonetheless, the finding that the ER membrane poses a barrier to mobility of H~2~O~2~ is consistent with the need to protect the cytosol and nucleus from lumenally generated H~2~O~2~, which has at least two sources: ERO1 and yet-to-be-identified parallel processes uncovered here. The cost of sluggish transport across the ER membrane is reflected in a diminished contribution of mitochondrially generated H~2~O~2~ to ER disulfide bond formation. This fits previous observations whereby inhibition of mitochondrial respiration in ERO1-deficient yeast cells did not affect the ability of PRDX4 to rescue disulfide bond formation ([@bib26]).

Materials and methods {#s06}
=====================

Plasmid construction {#s07}
--------------------

[Table S1](http://www.jcb.org/cgi/content/full/jcb.201506123/DC1){#supp4} lists the plasmids used, their laboratory names, description, published references, and a notation of their appearance in the figures.

Protein purification and in vitro enzymatic assays {#s08}
--------------------------------------------------

Human PDI (PDIA1 18-508) and HyPer were expressed in the *E. coli* BL21 (DE3) strain and purified with Ni-NTA affinity chromatography as previously described ([@bib3]). Time-dependent changes in redox of HyPer, in the presence of PDI or H~2~O~2~, were measured as described ([@bib2]; [@bib22]). In brief, the ratio of fluorescence emission at 535 nm of samples sequentially excited at 405 nm and 488 nm was measured using a Tecan 500 microplate reader (Tecan Group). For measurements of catalase activity in vitro, cells were homogenized in PBS by sonication; decomposition of substrate (H~2~O~2~) was traced by ultraviolet spectroscopy monitoring the absorbance at 240 nm, as described ([@bib19]). Specific activity was calculated using the following equation: U/mg = ΔA × min^−1^ × 1,000 × ml Reaction Mix/43.6 × mg protein, where U is activity units in micromoles per minute.

Transfections, immunoblotting, immunofluorescence, and cell culture {#s09}
-------------------------------------------------------------------

Mouse fibroblasts deficient in both ERO1a and ERO1b (DKO cells, genotype: *Ero1I^Gt(xst171)Byg/Gt(XST171)Byg^; Ero1Ib^Gt(P077G11)Wrst/Gt(P077G11)Wrs^*; [@bib25]) and ERO1a- and ERO1b-deficient cells compounded further by deletion of PRDX4 (TKO cells, genotype: *Ero1I^Gt(xst171)Byg/Gt(XST171)Byg^; Ero1Ib^Gt(P077G11)Wrst/Gt(P077G11)Wrs^; Prdx4^tm1.1JuFu/tm1.1JuFu^*; [@bib27]), as well as single deficiency of PRDX4 (PKO, genotype *Prdx4^tm1.1JuFu/tm1.1JuFu^*; [@bib10]; a gift from R. Edgar and A. Reddy, University of Cambridge Institute of Metabolic Science, Cambridge, England, UK) and wild-type counterpart cells were cultured in DMEM; RINm5F cells (ATCC) were cultured in RPMI (Sigma-Aldrich), both supplemented with 10% fetal calf serum.

Transfections were performed using the Neon Transfection System (Invitrogen) applying 3 µg of ERroGFP2 or ERHyPer DNA, 6 µg of PRDX4, and 10 µg of catalase DNA/10^6^ cells.

For immunoblotting, cells from confluent 100-mm dishes were washed in PBS and lysed in 0.5% Triton X-100, 150 mM NaCl, 20 mM Hepes, pH 7.4, and protease inhibitors. Proteins were resolved by 12% SDS-PAGE and blotted with rabbit ERO1α, ERO1β, or PRDX4 antisera ([@bib26]) or with mouse monoclonal anti--actin IgG (Abcam).

Before immunofluorescence staining, cells were fixed with 4% paraformaldehyde, permeabilized with 0.5% Triton X-100/PBS, and blocked with 10% goat serum/PBS. To visualize the ER, rabbit anti--calreticulin IgG (Pierce) and goat anti--rabbit IgG conjugated to DyLight 543 (Jackson ImmunoResearch Laboratories) were used as the primary and secondary antibodies, respectively. Catalase was detected using goat IgG (Abcam) and donkey anti--goat IgG conjugated to Alexa Fluor 488 (Jackson ImmunoResearch Laboratories) as primary and secondary antibodies, respectively. ERroGFP2 and ERHyPer were detected by their fluorescence. Nuclei were counterstained with Hoechst 33342 (2 µg/ml in PBS).

Confocal microscopy and image analysis {#s10}
--------------------------------------

Cells transfected with the redox reporters (roGFP2 or HyPer) were acquired and analyzed by a laser scanning confocal microscopy system running Zen Blue software (LSM 510 Meta; Carl Zeiss) with a Plan-Apo Chromat 60× oil immersion lens (NA 1.4), coupled to a microscope incubator, maintaining standard tissue culture conditions (37°C, 5% CO~2~; Okolab), in complete DMEM culture medium. Fluorescence ratiometric intensity images (512 × 512 points, 16-bit) of live cells were acquired. A 405-nm diode and 488-nm Argon lasers (2% and 0.5% output, respectively) were used for excitation of the ratiometric probes in multitrack mode with an HFT 488/405 beam splitter. The signal was detected with 518- to 550-nm filters, and the detector gain was arbitrarily adjusted to yield an intensity ratio of the two channels approximating one.

The recovery *t*~1/2~ was extracted from fitting the intensity ratio changes over time to an exponential equation: I (t) = A (1 − e^−τt^), where I is intensity, t is time, and τ is the fitted parameter. After obtaining τ from the fitting curve, the recovery *t*~1/2~ was calculated using the formula *t*~1/2~ = ln(0.5)/−τ. Images were analyzed using ImageJ (National Institutes of Health) and Zen (Carl Zeiss) software.

Online supplemental material {#s11}
----------------------------

Fig. S1 shows measurements of ERroGFP2 reoxidation kinetics in PRDX4 KO cells. Fig. S2 shows HyPer oxidation rates driven by H~2~O~2~ or PDI, in vitro and in vivo. Table S1 lists the plasmids used in this study. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201506123/DC1>. Additional data are available in the JCB DataViewer at <http://dx.doi.org/10.1083/jcb.201506123.dv>.
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